openPR Logo
Press release

Global Microbial Fermentation Technology Market Size is projected to grow at a CAGR of 5.24% by 2032, estimates DelveInsight

12-03-2025 04:17 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Global Microbial Fermentation Technology Market

Global Microbial Fermentation Technology Market

DelveInsight's analysis indicates that the microbial fermentation technology market is witnessing robust expansion, driven largely by the rising burden of chronic conditions such as cancer and an array of infectious diseases including HIV, hepatitis B and C, and influenza. Growing demand for advanced therapeutic modalities such as cell therapies, monoclonal antibodies, recombinant proteins, and gene therapies is further accelerating market momentum. Additionally, innovations in synthetic biology and precision fermentation are significantly enhancing production efficiency, scalability, and product quality, encouraging broader adoption. Coupled with continuous improvements in bioprocessing technologies, these trends are projected to fuel substantial market growth from 2025 to 2032.

The latest DelveInsight report, "Microbial Fermentation Technology Market Insights, Competitive Landscape and Market Forecast-2032," presents an in-depth evaluation of the current market status, future outlook, emerging product developments, key challenges, and major market drivers and restraints. It also highlights prominent products in development and profiles leading companies active in the microbial fermentation technology sector.

To explore how North America has emerged as the frontrunner in this market, access key insights in the Microbial Fermentation Technology Market Trends snapshot: https://www.delveinsight.com/sample-request/microbial-fermentation-technology-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Microbial Fermentation Technology Overview
Microbial fermentation technology involves the use of microorganisms such as bacteria, yeast, and fungi to transform organic substrates into valuable products. By maintaining optimal fermentation conditions, including pH, temperature, and oxygen levels, these microbes help produce enzymes, antibiotics, vaccines, biofuels, amino acids, vitamins, and a variety of industrial and pharmaceutical materials.

This technology has become indispensable across industries such as biopharmaceuticals, food and beverages, agriculture, bioenergy, and environmental management, offering scalable and cost-efficient production of biologically derived compounds.

DelveInsight Microbial Fermentation Technology Market Analysis
The microbial fermentation technology market was valued at USD 33,956.10 million in 2024 and is expected to grow at a CAGR of 5.24% between 2025 and 2032.

Microbial Fermentation Technology Market Insights
North America is projected to remain the leading region throughout the forecast period. The region's dominance is supported by the rising prevalence of infectious diseases including tuberculosis, influenza, and emerging pathogens alongside growing cancer rates. Strong research and development capabilities, the presence of major biopharmaceutical companies, and advanced healthcare infrastructure further reinforce North America's leadership position in this market.

For more highlights and insights on the latest market developments, explore the Microbial Fermentation Technology Insights snapshot: https://www.delveinsight.com/sample-request/microbial-fermentation-technology-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Recent Developments in the Microbial Fermentation Technology Market
• June 2024: Danone, Michelin, DMC Biotechnologies, and Crédit Agricole Centre France launched the Biotech Open Platform, a state-of-the-art biotechnology hub dedicated to advancing large-scale precision fermentation. The initiative aims to strengthen the development of sustainable bio-based ingredients and materials.
• March 2024: Novel Bio, recognized for its next-generation biomanufacturing technologies for plasmid DNA in advanced genetic therapies, partnered with Culture Biosciences to accelerate scalable fermentation process development for its proprietary NBx PlatformTM.
These strategic developments are expected to significantly contribute to the rapid growth of the microbial fermentation technology market in the coming years.

Key Companies in the Microbial Fermentation Technology Market
Major Microbial Fermentation Technology Companies driving innovation in this sector include:
Novozymes A/S, Lonza Group AG, Koninklijke DSM N.V., Biocon Limited, Ajinomoto Co., Inc., Evonik Industries AG, Intralytix, Inc., UAS Laboratories LLC, Second Genome, Inc., Chr. Hansen Holding A/S, Ginkgo Bioworks, Amyris, Inc., Lesaffre, BioVectra Inc., TerraVia Holdings, Inc., among others.

For insights into the top MedTech innovators shaping the future landscape, explore the Key Microbial Fermentation Technology Companies snapshot: : https://www.delveinsight.com/sample-request/microbial-fermentation-technology-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Microbial Fermentation Technology Market Landscape Overview
Global health authorities and regulatory agencies are increasingly contributing to the advancement of antibiotic development. Organizations such as the Global Antibiotic Research & Development Partnership (GARDP), BARDA, and the European Innovative Medicines Initiative (IMI) continue to fund and support antibiotic R&D efforts. Their initiatives are critical in addressing the escalating challenge of antimicrobial resistance (AMR) and ensuring sustainable access to effective therapies.

With the combined effect of rising infectious disease prevalence, growing AMR concerns, ongoing scientific advancements, and strong governmental and institutional support, the antibiotics segment is expected to achieve notable growth-thereby strengthening the overall microbial fermentation technology market from 2025 to 2032.

Scope of the Microbial Fermentation Technology Market Report
• Coverage: Global
• Study Period: 2022-2032
• Microbial Fermentation Technology Market Segmentation by Product Type:
Antibiotics, Probiotics, Monoclonal Antibodies, Biosimilars, Recombinant Proteins & Vaccines, Enzymes, Others
• Microbial Fermentation Technology Market Segmentation by End-User:
Pharmaceutical & Biotechnology Companies, CROs, CMOs & CDMOs, Academic & Research Institutions
• Geographical Segmentation:
North America, Europe, Asia-Pacific, Rest of the World
• Notable Microbial Fermentation Technology Companies:
Novozymes A/S, Lonza Group AG, Koninklijke DSM N.V., Biocon Limited, Ajinomoto Co., Inc., Evonik Industries AG, Intralytix, Inc., UAS Laboratories LLC, Second Genome, Inc., Chr. Hansen Holding A/S, Ginkgo Bioworks, Amyris, Inc., Lesaffre, BioVectra Inc., TerraVia Holdings, Inc., and others
• Additional Inclusions:
Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL Insights, Analyst Perspectives

Explore how the microbial fermentation technology market is expected to evolve through 2032 by viewing the Market Analysis snapshot: : https://www.delveinsight.com/sample-request/microbial-fermentation-technology-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Microbial Fermentation Technology Market Size is projected to grow at a CAGR of 5.24% by 2032, estimates DelveInsight here

News-ID: 4297700 • Views:

More Releases from DelveInsight Business Research

Airway Management Devices Market is projected to reach USD 2.29 billion by 2032, estimates DelveInsight
Airway Management Devices Market is projected to reach USD 2.29 billion by 2032, …
DelveInsight's latest assessment indicates that the rising incidence of asthma, COPD, and other respiratory conditions coupled with an increase in surgical procedures and worsening global air quality is significantly boosting the need for advanced airway management devices. Additionally, improved awareness, earlier diagnosis of respiratory diseases, and the introduction of technologically enhanced products are further accelerating market expansion. DelveInsight's report, "Airway Management Devices Market Insights, Competitive Landscape and Market Forecast 2032," provides
Postpartum Depression Market Set to Grow Substantially Through 2034, DelveInsight Projects
Postpartum Depression Market Set to Grow Substantially Through 2034, DelveInsigh …
DelveInsight's "Postpartum Depression Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Postpartum Depression, historical and forecasted epidemiology as well as the Postpartum Depression market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Postpartum Depression market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Postpartum Depression Market Forecast https://www.delveinsight.com/sample-request/postpartum-depression-ppd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Kidney Transplant Rejection Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports
Kidney Transplant Rejection Market to Show Remarkable Growth Trends from 2024 to …
DelveInsight's "Kidney Transplant Rejection Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Kidney Transplant Rejection, historical and forecasted epidemiology as well as the Kidney Transplant Rejection market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Kidney Transplant Rejection market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Kidney Transplant Rejection
Fuchs Endothelial Corneal Dystrophy Market Predicted to See Upsurge Through 2034, Highlights DelveInsight
Fuchs Endothelial Corneal Dystrophy Market Predicted to See Upsurge Through 2034 …
DelveInsight's "Fuchs Endothelial Corneal Dystrophy Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Fuchs Endothelial Corneal Dystrophy, historical and forecasted epidemiology as well as the Fuchs Endothelial Corneal Dystrophy market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Fuchs Endothelial Corneal Dystrophy market outlook, drug uptake, treatment scenario and epidemiology trends, Click

All 5 Releases


More Releases for Microbial

Microbial Contamination Identification Market Size Analysis by Application, Type …
According to Market Research Intellect, the global Microbial Contamination Identification market under the Aerospace and Defense category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for microbial contamination identification is expanding steadily due to growing concerns about product safety in industries
Major Market Shift in Microbial Identification Industry: Automated Systems Trans …
What Is the Forecasted Market Size and Growth Rate for the Microbial Identification Market? In the last few years, the size of the microbial identification market has seen significant expansion. It is projected to rise from $5.57 billion in 2024 to $6.44 billion in 2025, with a compound annual growth rate (CAGR) of 15.7%. The exponential growth during the historic period is credited to initiatives and funding from the government which
Microbial Food Ingredient Market Harvesting the Power of Microbes: The Booming M …
Microbial Food Ingredient Market Worth 4.97 Bn 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Microbial Food Ingredient Market"- By Microorganism (Bacteria, Yeast, Mold), Product Type (Starter Cultures, Protective Cultures, Probiotic Cultures), Strain (Single-Strain Culture, Multi-Strain Culture, Multi-Strain Mixed Culture) End User (Food and Beverage Manufacturers, Animal Feed Additives), Industry Trends, and Global Forecasts, 2022-2035 And
Microbial Identification Market: Unraveling Microbial Mysteries on the Path to U …
The global microbial identification market is expected to be worth US$ 3.7 billion in 2022, and to grow at a CAGR of 11.3% between 2022 and 2032, to be worth around US$ 10.7 billion by 2032. Rising demand for microbial identification products across various end-user sectors such as pharmaceutical and biotechnology, food and beverage, water and environment, diagnostic laboratories, and independent research laboratories is driving the microbial identification market. Based on
Microbial Fermentation Technology Market
According to the report, the global microbial fermentation technology market was valued at US$1,493.8 bn in 2016 and is projected to expand at a CAGR of 5.7% from 2017 to 2025, rising to a valuation of US$2,447.5 bn in 2025. Market Definition: When fungus and other microbes create secondary metabolites, microbial fermentation takes place. When the conditions are ideal, these bacteria may convert affordable nitrogen and carbon sources into crucial intermediates or
Microbial Bioreactor Market
The Global Microbial Bioreactor Market is expected to grow at a CAGR of 20.1% during the forecasting period (2022-2029). Micro bioreactors serve as a multitude of scale-down needs for bioprocesses based on mammalian cells. Microbioreactor technology has allowed for rapid advancements in biotechnology process development and investigation of various biological systems from industrial biotechnology and pharmaceutical biotechnology. Micro bioreactors range in complexity from simple micro-tier-based systems to complex automated parallel bioreactors